Skip to main content

Advertisement

Log in

Osteoporosis in chronic liver disease

  • Invited Commentary
  • Published:
Current Gastroenterology Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Rubin LA, Hawker GA, Peltekova VD, et al.: Determinants of peak bone mass, clinical and genetic analyses in a young female Canadian cohort. J Bone Miner Res 1999, 14:633–643.

    Article  PubMed  CAS  Google Scholar 

  2. Springer JE, Cole DEC, Rubin LA, et al.: Vitamin D receptor genotypes as independent genetic predictors of decreased bone mineral density in primary biliary cirrhosis. Gastroenterology 1999, in press.

  3. Kobayashi S, Inoue S, Hosoi T, et al.: Association of bone mineral density with polymorphism of the estrogen receptor gene.J Bone Miner Res 1996, 11:306–311.

    Article  PubMed  CAS  Google Scholar 

  4. Uitterlinden AG, Burger H, Huang Q, et al: Relation of alleles of the collagen type 1a1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women. N Engl J Med 1998, 338:1016–1021.

    Article  PubMed  CAS  Google Scholar 

  5. Janes CH, Dickson ER, Okazaki R: Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice.J Clin Invest 1995, 95:2581–2586.

    Article  PubMed  CAS  Google Scholar 

  6. Slatopolsky E: The interaction of parathyroid hormone and aluminum in renal osteodystrophy.Kidney Int 1987, 31:842–854.

    PubMed  CAS  Google Scholar 

  7. Diamond T, Stiel D, Mason R, et al: Serum vitamin D metabolites are not responsible for low turnover osteoporosis in chronic liver disease.J Clin Endocrin Metab 1989, 69:1234–1239.

    Article  CAS  Google Scholar 

  8. Matloff DS, Kaplan MM, Neer RM, et al: Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxyvitamin D3 treatment.Gastroenterology 1982, 83:97–102.

    PubMed  CAS  Google Scholar 

  9. Wang YJ, Wu JC, Lee SD, et al.: Gonadal dysfunction and changes in sex hormones in postnecrotic cirrhotic men: a matched study with alcoholic cirrhotic men. Hepatogastroenterology 1991, 38:531–534.

    PubMed  CAS  Google Scholar 

  10. Hodgson SF, Dickson ER, Eastell R, et al.: Rates of cancellous bone remodeling and turnover in osteopenia associated with primary biliary cirrhosis. Bone 1993, 14:819–827.

    Article  PubMed  CAS  Google Scholar 

  11. Hay JE, Lindor KD, Wiesner RH, et al.: The metabolic bone disease of primary sclerosing cholangitis. Hepatology 1991, 14:257–261.

    PubMed  CAS  Google Scholar 

  12. Angulo P, Therneau TM, Jorgensen RA, et al.: Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression. J Hepatol 1998, 29:729–735.

    Article  PubMed  CAS  Google Scholar 

  13. Eastell R, Dickson ER, Hodgson S, et al.: Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis. Hepatology 1991, 14:296–300.

    Article  PubMed  CAS  Google Scholar 

  14. Porayko MK, Wiesner RH, Hay JE, et al.: Bone disease in liver transplant recipients: incidence, timing and risk factors Transplant Proc 1991, 23:1462–1465.

    PubMed  CAS  Google Scholar 

  15. Monegal A, Navasa M, Guanabens N, et al.: Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation. Calcif Tissue Int 1997, 60:148–154.

    Article  PubMed  CAS  Google Scholar 

  16. Bonkovsky HL, Hawkins M, Steinberg K, et al.: Prevalence and prediction of osteopenia in chronic liver disease. Hepatology 1990, 12:273–280.

    Article  PubMed  CAS  Google Scholar 

  17. Crippin JS, Jorgensen RA, Dickson ER, Lindor KD: Hepatic osteodystrophy in primary biliary cirrhosis: effects of medical treatment. Am J Gastroenterol 1994, 89:47–50.

    PubMed  CAS  Google Scholar 

  18. Guanabens N, Pares A, Monegal A, et al.: Etidronate versus fluoride for treatment of osteopenia in primary biliary cirrhosis: preliminary results after 2 years. Gastroenterology 1997, 113:219–224.

    Article  PubMed  CAS  Google Scholar 

  19. Adachi JD, Bensen GB, Brown J, et al.: Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med 1997, 337:382–387.

    Article  PubMed  CAS  Google Scholar 

  20. Wolfhagen FHJ, van Buren HR, denOuden JW, et al.: Cyclical etidronate in the prevention of bone loss in corticosteroidtreated primary biliary cirrhosis: a prospective, dcontrolled pilot study. J Hepatol 1997, 26:325–330.

    Article  PubMed  CAS  Google Scholar 

  21. Lindor KD, Jorgensen RA: Etidronate for cholestasis induced osteoporosis: a randomized trial [abstract]. Gastroenterology 1999,116:A1239.

    Google Scholar 

  22. Lindor KD, Janes CH, Crippen JS, et al.: Bone disease in primary biliary cirrhosis: does ursodeoxycholic acid make a difference? Hepatology 1995, 21:389–392.

    PubMed  CAS  Google Scholar 

  23. Floreani A, Chiaramonte M, Giannini S, et al. Longitudinal study on osteodystrophy in primary biliary cirrhosis (PBC) and a pilot study on calcitonin treatment. J Hepatol 1991, 12:217–223.

    Article  PubMed  CAS  Google Scholar 

  24. Dawson-Hughes B, Haris SS, Krall EA, Dallal GE: Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997, 337:670–676.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Heathcote, J. Osteoporosis in chronic liver disease. Curr Gastroenterol Rep 1, 455–458 (1999). https://doi.org/10.1007/s11894-999-0001-y

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11894-999-0001-y

Keywords

Navigation